# KOHLS Corp: financial statements, quarterly

KSS · NYSE · CIK 885639 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 29

Pages: [Overview](/companies/kss.md) · [Financials](/companies/kss/financials.md) · [Filings](/companies/kss/filings.md) · [Insiders](/companies/kss/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kss/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,054](/filings/0000950170-24-133680.md) | [5,956 d](/filings/0001193125-26-115982.md) | [3,382](/filings/0000950170-25-083079.md) | [3,732](/filings/0000950170-25-113028.md) | [3,710](/filings/0001193125-25-306677.md) | [5,397 d](/filings/0001193125-26-115982.md) | [3,233](/filings/0001193125-26-257402.md) | [3,546](/filings/0001193125-26-381893.md) | [3,575](/filings/0001193125-25-306677.md) | [5,173 d](/filings/0001193125-26-115982.md) | [3,167](/filings/0001193125-26-257402.md) | [3,515](/filings/0001193125-26-381893.md) |
| Cost of revenue | $m | [2,349](/filings/0000950170-24-133680.md) | [3,860 d](/filings/0001193125-26-115982.md) | [1,923](/filings/0000950170-25-083079.md) | [2,128](/filings/0000950170-25-113028.md) | [2,137](/filings/0001193125-25-306677.md) | [3,473 d](/filings/0001193125-26-115982.md) | [1,834](/filings/0001193125-26-257402.md) | [2,011](/filings/0001193125-26-381893.md) | [2,059](/filings/0001193125-25-306677.md) | [3,324 d](/filings/0001193125-26-115982.md) | [1,802](/filings/0001193125-26-257402.md) | [1,893](/filings/0001193125-26-381893.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [1,360](/filings/0000950170-24-133680.md) | [1,610 d](/filings/0001193125-26-115982.md) | [1,228](/filings/0000950170-25-083079.md) | [1,250](/filings/0000950170-25-113028.md) | [1,291](/filings/0001193125-25-306677.md) | [1,539 d](/filings/0001193125-26-115982.md) | [1,164](/filings/0001193125-26-257402.md) | [1,199](/filings/0001193125-26-381893.md) | [1,263](/filings/0001193125-25-306677.md) | [1,463 d](/filings/0001193125-26-115982.md) | [1,145](/filings/0001193125-26-257402.md) | [1,188](/filings/0001193125-26-381893.md) |
| Operating income | $m | [157](/filings/0000950170-24-133680.md) | [299 d](/filings/0001193125-26-115982.md) | [43.0](/filings/0000950170-25-083079.md) | [166](/filings/0000950170-25-113028.md) | [98.0](/filings/0001193125-25-306677.md) | [126 d](/filings/0001193125-26-115982.md) | [60.0](/filings/0001193125-26-257402.md) | [279](/filings/0001193125-26-381893.md) | [73.0](/filings/0001193125-25-306677.md) | [212 d](/filings/0001193125-26-115982.md) | [46.0](/filings/0001193125-26-257402.md) | [261](/filings/0001193125-26-381893.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.0](/filings/0000950170-24-133680.md) | [31.0 d](/filings/0001193125-26-115982.md) | [(13.0)](/filings/0000950170-25-083079.md) | [14.0](/filings/0000950170-25-113028.md) | [0.0 d](/filings/0001193125-25-306677.md) | [4.0 d](/filings/0001193125-26-115982.md) | [(1.0)](/filings/0001193125-26-257402.md) | [48.0](/filings/0001193125-26-381893.md) | [(10.0)](/filings/0001193125-25-306677.md) | [28.0 d](/filings/0001193125-26-115982.md) | [(3.0)](/filings/0001193125-26-257402.md) | [47.0](/filings/0001193125-26-381893.md) |
| Net income | $m | [59.0](/filings/0000950170-24-133680.md) | [186 d](/filings/0001193125-26-115982.md) | [(27.0)](/filings/0000950170-25-083079.md) | [66.0](/filings/0000950170-25-113028.md) | [22.0](/filings/0001193125-25-306677.md) | [48.0 d](/filings/0001193125-26-115982.md) | [(15.0)](/filings/0001193125-26-257402.md) | [153](/filings/0001193125-26-381893.md) | [8.0](/filings/0001193125-25-306677.md) | [125 d](/filings/0001193125-26-115982.md) | [(14.0)](/filings/0001193125-26-257402.md) | [151](/filings/0001193125-26-381893.md) |
| Diluted EPS | $ per share | [0.53](/filings/0000950170-24-133680.md) | not reported | [(0.24)](/filings/0000950170-25-083079.md) | [0.59](/filings/0000950170-25-113028.md) | [0.20](/filings/0001193125-25-306677.md) | not reported | [(0.13)](/filings/0001193125-26-257402.md) | [1.35](/filings/0001193125-26-381893.md) | [0.07](/filings/0001193125-25-306677.md) | not reported | [(0.13)](/filings/0001193125-26-257402.md) | [1.28](/filings/0001193125-26-381893.md) |
| Basic EPS | $ per share | [0.54](/filings/0000950170-24-133680.md) | not reported | [(0.24)](/filings/0000950170-25-083079.md) | [0.59](/filings/0000950170-25-113028.md) | [0.20](/filings/0001193125-25-306677.md) | not reported | [(0.13)](/filings/0001193125-26-257402.md) | [1.37](/filings/0001193125-26-381893.md) | [0.08](/filings/0001193125-25-306677.md) | not reported | [(0.13)](/filings/0001193125-26-257402.md) | [1.34](/filings/0001193125-26-381893.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000950170-24-133680.md) | [0.2](/filings/0000950170-25-042662.md) | [0.2](/filings/0000950170-25-083079.md) | [0.2](/filings/0000950170-25-113028.md) | [0.2](/filings/0001193125-25-306677.md) | [0.1](/filings/0001193125-26-115982.md) | [0.2](/filings/0001193125-26-257402.md) | [0.2](/filings/0001193125-26-381893.md) | [0.1](/filings/0001193125-25-306677.md) | [0.7](/filings/0001193125-26-381893.md) | [0.4](/filings/0001193125-26-257402.md) | [0.8](/filings/0001193125-26-381893.md) |
| Current assets | $bn | [4.7](/filings/0000950170-24-133680.md) | [3.4](/filings/0000950170-25-042662.md) | [3.7](/filings/0000950170-25-083079.md) | [3.7](/filings/0000950170-25-113028.md) | [4.6](/filings/0001193125-25-306677.md) | [3.4](/filings/0001193125-26-115982.md) | [3.6](/filings/0001193125-26-257402.md) | [3.5](/filings/0001193125-26-381893.md) | [4.3](/filings/0001193125-25-306677.md) | [3.7](/filings/0001193125-26-381893.md) | [3.7](/filings/0001193125-26-257402.md) | [4.0](/filings/0001193125-26-381893.md) |
| Total assets | $bn | [15.5](/filings/0000950170-24-133680.md) | [14.0](/filings/0000950170-25-042662.md) | [14.3](/filings/0000950170-25-083079.md) | [14.2](/filings/0000950170-25-113028.md) | [15.1](/filings/0001193125-25-306677.md) | [13.6](/filings/0001193125-26-115982.md) | [13.6](/filings/0001193125-26-257402.md) | [13.4](/filings/0001193125-26-381893.md) | [14.1](/filings/0001193125-25-306677.md) | [13.4](/filings/0001193125-26-381893.md) | [13.2](/filings/0001193125-26-257402.md) | [13.4](/filings/0001193125-26-381893.md) |
| Current liabilities | $bn | [4.2](/filings/0000950170-24-133680.md) | [2.6](/filings/0000950170-25-042662.md) | [3.0](/filings/0000950170-25-083079.md) | [3.4](/filings/0000950170-25-113028.md) | [4.4](/filings/0001193125-25-306677.md) | [3.1](/filings/0001193125-26-115982.md) | [3.3](/filings/0001193125-26-257402.md) | [2.5](/filings/0001193125-26-381893.md) | [3.3](/filings/0001193125-25-306677.md) | [2.5](/filings/0001193125-26-381893.md) | [2.5](/filings/0001193125-26-257402.md) | [2.7](/filings/0001193125-26-381893.md) |
| Long-term debt | $bn | [1.6](/filings/0000950170-24-133680.md) | [1.6](/filings/0000950170-25-042662.md) | [1.6](/filings/0000950170-25-083079.md) | [1.2](/filings/0000950170-25-113028.md) | [1.2](/filings/0001193125-25-306677.md) | [1.2](/filings/0001193125-26-115982.md) | [1.2](/filings/0001193125-26-257402.md) | [1.5](/filings/0001193125-26-381893.md) | [1.5](/filings/0001193125-25-306677.md) | [1.4](/filings/0001193125-26-381893.md) | [1.4](/filings/0001193125-26-257402.md) | [1.3](/filings/0001193125-26-381893.md) |
| Current portion of debt | $bn | [0.1](/filings/0000950170-24-133680.md) | not reported | not reported | [0.4](/filings/0000950170-25-113028.md) | [0.4](/filings/0001193125-25-306677.md) | [0.4](/filings/0001193125-26-115982.md) | [0.4](/filings/0001193125-26-257402.md) | [0.0](/filings/0000950170-25-113028.md) | [0.0](/filings/0001193125-25-306677.md) | [0.0](/filings/0001193125-26-257402.md) | [0.0](/filings/0001193125-26-257402.md) | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.8](/filings/0000950170-24-133680.md) | [3.9](/filings/0001193125-26-115982.md) | [3.8](/filings/0000950170-25-083079.md) | [3.8](/filings/0000950170-25-113028.md) | [3.8](/filings/0001193125-25-306677.md) | [3.8](/filings/0001193125-26-115982.md) | [3.8](/filings/0001193125-26-257402.md) | [3.9](/filings/0001193125-26-381893.md) | [3.9](/filings/0001193125-25-306677.md) | [4.0](/filings/0001193125-26-381893.md) | [4.0](/filings/0001193125-26-257402.md) | [4.2](/filings/0001193125-26-381893.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [151 d](/filings/0000950170-24-133680.md) | [789 d](/filings/0001193125-26-115982.md) | [(7.0)](/filings/0000950170-25-083079.md) | [254 d](/filings/0000950170-25-113028.md) | [(195) d](/filings/0001193125-25-306677.md) | [596 d](/filings/0001193125-26-115982.md) | [(92.0)](/filings/0001193125-26-257402.md) | [598 d](/filings/0001193125-26-381893.md) | [124 d](/filings/0001193125-25-306677.md) | [750 d](/filings/0001193125-26-115982.md) | [(74.0)](/filings/0001193125-26-257402.md) | [552 d](/filings/0001193125-26-381893.md) |
| Capital expenditure | $m | [157 d](/filings/0000950170-24-133680.md) | [82.0 d](/filings/0001193125-26-115982.md) | [126](/filings/0000950170-25-083079.md) | [113 d](/filings/0000950170-25-113028.md) | [128 d](/filings/0001193125-25-306677.md) | [99.0 d](/filings/0001193125-26-115982.md) | [110](/filings/0001193125-26-257402.md) | [90.0 d](/filings/0001193125-26-381893.md) | [108 d](/filings/0001193125-25-306677.md) | [64.0 d](/filings/0001193125-26-115982.md) | [84.0](/filings/0001193125-26-257402.md) | [62.0 d](/filings/0001193125-26-381893.md) |
| Dividends paid | $m | [55.0 d](/filings/0000950170-24-133680.md) | [55.0 d](/filings/0001193125-26-115982.md) | [55.0](/filings/0000950170-25-083079.md) | [56.0 d](/filings/0000950170-25-113028.md) | [55.0 d](/filings/0001193125-25-306677.md) | [56.0 d](/filings/0001193125-26-115982.md) | [14.0](/filings/0001193125-26-257402.md) | [14.0 d](/filings/0001193125-26-381893.md) | [14.0 d](/filings/0001193125-25-306677.md) | [14.0 d](/filings/0001193125-26-115982.md) | [14.0](/filings/0001193125-26-257402.md) | [14.0 d](/filings/0001193125-26-381893.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [119](/filings/0000950170-23-067031.md) | [111](/filings/0000950170-24-069880.md) | [111](/filings/0000950170-24-103988.md) | [111](/filings/0000950170-24-133680.md) | [111](/filings/0000950170-24-069880.md) | [112](/filings/0000950170-25-113028.md) | [112](/filings/0001193125-25-306677.md) | [111](/filings/0001193125-26-257402.md) | [114](/filings/0001193125-26-381893.md) | [115](/filings/0001193125-25-306677.md) | [112](/filings/0001193125-26-257402.md) | [118](/filings/0001193125-26-381893.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 113,376,445 at 2026-08-28, from the cover of the [10-Q filed 2026-09-03](/filings/0001193125-26-381893.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.